Back to search results

Internet-Based Parent-Child Interaction Therapy (I-PCIT) for Pediatric Cancer

This study is exploring whether a telehealth program called Internet-Based Parent-Child Interaction Therapy (I-PCIT) can help parents improve their child's behavior. This program is for parents of children aged 2-12 who have received or are currently receiving cancer treatment at Johns Hopkins All Children's Hospital. I-PCIT has two parts: one to improve positive parent-child interactions and another to help parents manage their child's behavior. Researchers will measure how easy it is to complete I-PCIT and how much parents like the program after about 37 weeks. The study aims to enroll 300 participants, but its current status is unclear.

Study design
This is an interventional study where participants will be randomly assigned to either receive I-PCIT immediately or be on a waitlist for 5-6 months. The study plans to enroll 300 participants.
What's involved
You would complete I-PCIT sessions with a clinician and fill out 3-4 follow-up surveys after an initial screening survey.
Compensation
Not stated in the trial record.
Follow-up
The study assesses feasibility and acceptability of I-PCIT at 37 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06346782

Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer

Recruiting
NAAll AgesInterventionalSupportive care
Johns Hopkins All Children's Hospital
~300 participants
Updated 2026-04-30 on ClinicalTrials.gov
What's tested:Internet-Based Parent-Child Interaction Therapy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
I-PCIT Feasibility as assessed by intervention completion
Measured over 37 weeks
+1 more outcome measured

Conditions

Pediatric Cancer
Oncology
Disruptive Behavior

Explore related trials

Childhood Malignant Neoplasm

Where it's being run

1 sites across 1 states
Florida1

Study leadership

  • Melissa Faith, Ph.D. · PRINCIPAL_INVESTIGATOR · Johns Hopkins All Children's Hospital

Who to contact

Melissa Faith, Ph.D.
[email protected]
7272958477
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Participants will be parents of 2-12 year-old children who (1) currently or previously received cancer treatment and/or long-term cancer follow-up care at Johns Hopkins All Children's Hospital (JHACH).
The child's cancer treatment must have included or plan to include chemotherapy and/or radiation.
The child's cancer diagnosis must have been conferred at least 6 weeks prior to study enrollment. If a patient's cancer relapses during the study period, the patient's oncologist must agree to the patient continuing in this intervention.
The parent must have access to reliable internet service (e.g., in their own home, in a friend or family member's home, via cell phone carrier) and their own smartphone, tablet, or computer to participate in telehealth intervention sessions.

Exclusion

Parents will be excluded if they or their child have cognitive, motor, or language delays that would preclude participation, as observed by research staff or listed in the child's medical record. Hearing impaired parents will also be excluded because I-PCIT requires the coach to verbally coach parents via bug-in-ear.
Parents will be excluded if their child is expected to undergo bone marrow transplant (BMT) during the study or has received BMT within 2 months of study enrollment.
The child must not be receiving end of life care, as determined by medical chart review and/or consultation with the patient's medical team.

What this trial measures

  • I-PCIT Feasibility as assessed by intervention completion37 weeks

    Investigators will determine I-PCIT was feasible if at least 65% of parents in the I-PCIT arm reach minimum benchmark for PCIT completion.

  • I-PCIT Acceptability as assessed by the Treatment Evaluation Inventory Short form37 weeks

    Investigators will consider I-PCIT acceptable if at least 80% of parents demonstrate scores of at least 27 on the Treatment Evaluation Inventory-Short Form. Scale range is 9 to 45. Higher scores correspond to greater acceptability of the intervention.